Skip to main content

Table 2 (Abstract A18). PRO scores of the BECOME study population set for Part 2 by PPTF and MMD

From: 13th European Headache Federation Congress 2019 - Abstracts

PRO questionnaires Part 2 (N=2419)
1 PPTF (n=1034) 2 PPTF(n=690) 3 PPTF (n=324) ≥4 PPTF (n=371)
EQ-5D-5L utility index score 0.78 (0.22) 0.76 (0.22) 0.72 (0.24) 0.72 (0.22)
EQ VAS score 70.3 (19.85) 66.8 (20.07) 64.5 (20.31) 62.0 (20.94)
HIT-6 total score 64.6 (5.74) 65.1 (5.69) 66.4 (5.03) 66.3 (5.14)
MIDAS disability grade IV, n (%) 802 (77.6) 565 (81.9) 283 (87.3) 332 (89.5)
  4–7 MMD(n=806) 8–14 MMD(n=605) ≥15 headache days/month, of which ≥8 are migraine days (n=1007)
EQ-5D-5L utility index score 0.82 (0.19) 0.81 (0.19) 0.68 (0.24)
EQ VAS score 73.7 (17.88) 72.6 (17.74) 59.0 (20.71)
HIT-6 total score 63.6 (5.89) 65.0 (5.41) 66.7 (5.04)
MIDAS disability grade IV, n (%) 583 (72.3) 492 (81.3) 907 (90.1)
  1. All values are mean (SD) unless otherwise indicated. EQ-5D-5L, EuroQol 5 dimensions 5 levels; HIT, Headache Impact Test; MIDAS, migraine disability assessment; MMD, monthly migraine days; N, total number of patients; n, number of patients; PPTF, prior prophylactic treatment failures; PRO, patient-reported outcomes; VAS, visual analogue scale
\